Sangamo Therapeutics, Inc. (SGMO) Social Stream
SANGAMO THERAPEUTICS INC (SGMO) Price Targets From Analysts
The tables below show price targets and recommendations from analysts covering SANGAMO THERAPEUTICS INC.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Current Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2021-11-08 | 9 | $25 | $11 | $17.875 | $1.06 | 1586.32% |
| 2021-12-14 | 9 | $25 | $9 | $17.5 | $1.06 | 1550.94% |
| 2022-01-06 | 9 | $25 | $9 | $17.428 | $1.06 | 1544.15% |
| 2022-02-08 | 8 | $25 | $6 | $16.857 | $1.06 | 1490.28% |
| 2022-02-25 | 8 | $25 | $6 | $16.571 | $1.06 | 1463.3% |
| 2022-04-01 | 8 | $25 | $6 | $16.428 | $1.06 | 1449.81% |
| 2022-04-05 | 8 | $25 | $6 | $15.857 | $1.06 | 1395.94% |
| 2022-05-06 | 7 | $25 | $6 | $15 | $1.06 | 1315.09% |
| 2022-05-09 | 7 | $25 | $6 | $14.833 | $1.06 | 1299.34% |
| 2022-05-10 | 7 | $25 | $4.4 | $14.566 | $1.06 | 1274.15% |
| 2022-06-08 | 7 | $25 | $4.4 | $13.066 | $1.06 | 1132.64% |
| 2022-08-05 | 7 | $25 | $4.4 | $12.233 | $1.06 | 1054.06% |
| 2022-11-03 | 7 | $25 | $5 | $12 | $1.06 | 1032.08% |
| 2022-12-16 | 8 | $25 | $4 | $12.857 | $1.06 | 1112.92% |
| 2023-01-04 | 8 | $25 | $4 | $12.142 | $1.06 | 1045.47% |
| 2023-02-08 | 8 | $25 | $4 | $11.714 | $1.06 | 1005.09% |
| 2023-02-23 | 9 | $25 | $4 | $11.875 | $1.06 | 1020.28% |
| 2023-02-26 | 9 | $25 | $4 | $11.525 | $1.06 | 987.26% |
| 2023-02-27 | 9 | $25 | $4.2 | $13.025 | $1.06 | 1128.77% |
| 2023-02-28 | 9 | $25 | $4.2 | $12.9 | $1.06 | 1116.98% |
| 2023-03-03 | 9 | $16 | $4.2 | $11.65 | $1.06 | 999.06% |
| 2023-04-27 | 9 | $16 | $4.2 | $11.65 | $1.06 | 999.06% |
| 2023-04-28 | 9 | $16 | $1.5 | $11.175 | $1.06 | 954.25% |
| 2023-05-01 | 9 | $16 | $1.5 | $9.925 | $1.06 | 836.32% |
| 2023-07-20 | 10 | $16 | $1.5 | $8.925 | $1.06 | 741.98% |
| 2023-08-09 | 10 | $16 | $1.5 | $8.788 | $1.06 | 729.06% |
| 2023-08-14 | 10 | $10 | $1.5 | $6.122 | $1.06 | 477.55% |
| 2023-08-15 | 10 | $10 | $1.5 | $6.011 | $1.06 | 467.08% |
The Trend in the Analyst Price Target
Over the past 39 months, SGMO's average price target has gone down $15.59.
Over the past 47 weeks, SGMO's average upside potential has been 370.49%.
| Date | Number of Analysts | Highest Target Price | Lowest Target Price | Average Target Price | Share Price | Upside Potential |
|---|---|---|---|---|---|---|
| 2022-12-13 | 8 | 25 | 4.0 | 12.857 | 3.500 | 267.34% |
| 2022-12-16 | 8 | 25 | 4.0 | 12.857 | 3.440 | 273.75% |
| 2023-01-06 | 8 | 25 | 4.0 | 11.714 | 3.310 | 253.9% |
| 2023-04-27 | 9 | 16 | 4.2 | 11.650 | 1.600 | 628.12% |
| 2023-07-20 | 10 | 16 | 1.5 | 8.925 | 1.425 | 526.32% |
SGMO Broker Recommendations Summary
| Average Broker Rating | Strong Buy | Buy | Hold | Sell | Strong Sell | Analysts Issuing Recs |
|---|---|---|---|---|---|---|
| 1.6 | 7 | 1 | 1 | 0 | 0 | 10 |
The Trend in the Broker Recommendations
SGMO's average broker recommendation rating worsened by 0.03 over the prior 15 months.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- In the context of all US stocks, SANGAMO THERAPEUTICS INC's upside potential (average analyst target price relative to current price) is greater than 2907.77% of them.
- In the context of all US stocks, SANGAMO THERAPEUTICS INC's variance in analysts' estimates is lower than -2715.44% of them.
- In terms of how SANGAMO THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 462.34% of that group.
- SGMO has a higher number of analysts covering the stock than 1749.09% of stocks in the mid market cap category.
Stocks similar to SANGAMO THERAPEUTICS INC in the Pharmaceutical Products industry regarding analyst recommendations and price targets are VCEL, BCRX, and ENZN.
View All Top Stocks by Price Target
Is SGMO a Buy, Hold or Sell? See the POWR Ratings now!